Evaluation of skeletal muscle tremor due to bronchodilator agents
- PMID: 1166293
Evaluation of skeletal muscle tremor due to bronchodilator agents
Abstract
Two methods of measuring skeletal muscle tremor when evaluating this side-effect of treatment with bronchodilator agents are described. The first method, involving drawing a line between two sinus curves, is simple and requires no special equipment. Each time that the line crosses one of the sinus curves this is registered as an error. The large variation in results is a disadvantage but this drawing method can be used when more sophisticated devices are not available. Skeletal muscle tremor recorded with a Grass accelerometer gives accurate results provided the method is carefully standardized and the resting period adequate. The dose-response curves obtained during infusions of beta-adrenergic-stimulating drugs are linearly related to the dose given and are highly reproducible. The tremor ratio has the advantage over absolute values of smaller variations. The first of three 30-s periods registered gives the lowest tremor value and least variation, so this is the period used for analysis. Subjective experience of tremor is related to the Grass recording. In some cases, however, there is marked discrepancy between subjective and objective evaluation of tremor, which may be explained by the masking effect of concomitant heart stimulation. When tremor is related to heart rate in a single experiment a regression line is obtained. Another drug may give a different slope. The two slopes demonstrate the different selectivity of the drugs for the beta-receptors in the heart and skeletal muscle.
Similar articles
-
Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol.Int J Clin Pharmacol Ther Toxicol. 1987 Dec;25(12):673-82. Int J Clin Pharmacol Ther Toxicol. 1987. PMID: 2893778 Clinical Trial.
-
Comparison of infused and inhaled terbutaline in patients with asthma.Scand J Respir Dis. 1976;57(1):17-24. Scand J Respir Dis. 1976. PMID: 1273541
-
Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels.Eur J Respir Dis. 1982 Sep;63(5):399-409. Eur J Respir Dis. 1982. PMID: 7140872
-
In-vitro and in-vivo effects of theophylline and beta 2-adrenostimulants in combination.Eur J Respir Dis Suppl. 1980;109:83-91. Eur J Respir Dis Suppl. 1980. PMID: 6108228 Review.
-
Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.Drugs. 1977 Aug;14(2):81-104. doi: 10.2165/00003495-197714020-00001. Drugs. 1977. PMID: 19226 Review. No abstract available.
Cited by
-
Effect of prenalterol in asthmatic patients.Eur J Clin Pharmacol. 1982 Oct;23(4):297-302. doi: 10.1007/BF00613609. Eur J Clin Pharmacol. 1982. PMID: 6129142 Clinical Trial.
-
Safety outcomes of salbutamol: A systematic review and meta-analysis.Clin Respir J. 2023 Dec;17(12):1254-1264. doi: 10.1111/crj.13711. Epub 2023 Oct 16. Clin Respir J. 2023. PMID: 37844914 Free PMC article.
-
A critique of dosing strategies for beta-2 adrenergic agents and theophylline.Lung. 1981;159(6):295-314. doi: 10.1007/BF02713930. Lung. 1981. PMID: 6117677 Review. No abstract available.
-
Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.Eur J Clin Pharmacol. 1988;33 Suppl:S25-32. doi: 10.1007/BF00578409. Eur J Clin Pharmacol. 1988. PMID: 2836204 Clinical Trial.
-
Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists.Br J Clin Pharmacol. 1984 Aug;18(2):145-52. doi: 10.1111/j.1365-2125.1984.tb02446.x. Br J Clin Pharmacol. 1984. PMID: 6148957 Free PMC article.